PC12 and neuro 2a cells have different susceptibilities to acetylcholinesterase-amyloid complexes, amyloid25-35 fragment, glutamate, and hydrogen peroxide

Journal of Neuroscience Research

Volumn 56, Issue 6, 1999, Pages 620-631

  Calderón, Frances H ^a   Bonnefont, Andrea ^a   Muñoz, Francisco J ^a   Fernández, Virginia ^b   Videla, Luis A ^b   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

A amyloid; Acetylcholinesterase; Glutathione; Neuro 2a; Oxidative stress; PC12

Indexed keywords

17ALPHA ESTRADIOL; ACETYLCHOLINESTERASE; AMYLOID; ESTRADIOL; GLUTAMIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; PEPTIDE FRAGMENT; REACTIVE OXYGEN METABOLITE; TRITON X 100;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CATTLE; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; ESTRADIOL; GLUTAMIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE; KINETICS; MICE; NEUROBLASTOMA; NEURONS; OCTOXYNOL; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; TUMOR CELLS, CULTURED;

EID: 0033564579     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990615)56:6<620::AID-JNR8>3.0.CO;2-F     Document Type: Article

References (68)

1. Alvarez A, Opazo C, Alarcón R, Garrido J, Inestrosa NC. 1997. Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with growing fibrils. J Mol Biol 272:348-361.
2. Alvarez A, Alarcón R, Opazo C, Campos EO, Muñoz FJ, Calderón HF, Dajas F, Gentry MK, Doctor BP, De Mello FG, Inestrosa NC. 1998. Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 18:3213-3223.
3. Behl C. 1997. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease. (Review). Cell Tissue Res 290:471-480.
4. Behl C, Davis JB, Lesley R, Schubert D. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
5. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. 1997. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51: 535-541.
6. Behl C, Widmann M, Trapp T, Holsboer F. 1995. 17β Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482.
7. Bonnefont A, Muñoz FJ, Inestrosa NC. 1998. Estrogen protects neuronal cells against the cytotoxicity of the acetylcholinesterase-amyloid-β-peptide complexes. FEBS Lett 441:220-224.
8. Bridges RJ, Koh J-Y, Hatalsky CG, Cotman CW. 1991. Increased excitotoxic vulnerability of cortical cultures of with reduced levels of glutathione. Eur J Pharmacol 192:199-200.
9. Bronfman FC, Soto C, Tapia L, Tapia V, Inestrosa NC. 1996. Extracellular matrix regulates the amount of the β-amyloid precursor protein and its amyloidogenic fragments. J Cell Physiol 166:360-366.
10. Calderón FH, von Bernhardi R, De Ferrari G, Luza S, Aldunate R, Inestrosa NC. 1998. Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol Psychiatry 3:247-255.
11. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695.
12. De Ferrari GV, von Bernhardi R, Calderón FH, Luza SC, Inestrosa NC. 1998. Responses induced by Tacrine in neuronal and nonneuronal cell lines. J Neurosci Res 52:435-444.
13. Ellerby LM, Ellerby HM, Park SM, Holleran AL, Murphy AN, Fiskum G, Kane DJ, Testa MP, Kayalar C, Bredesen DE. 1996. Shift of the cellular oxidation-reduction potential in neuronal cells expressing Bcl-2. J Neurochem 67:1259-1267.
14. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
15. Fernández V, Simizu K, Barros SBM, Azzalis LA, Pimental R, Junqueira VBC, Videla LA. 1991. Effects of hyperthyroidism on rat liver glutathione metabolism: related enzymes' activities, efflux and turnover. Endocrinology 129:85-91.
16. Froissard P, Monrocq H, Duval D. 1997. Role of glutathione metabolism in the glutamate induced programmed cell death of neuronal-like PC12 cells. Eur J Pharmacol 12:93-99.
17. Goodman Y, Bruce AJ, Cheng B, Mattson MP. 1996. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844
18. Goodman Y, Mattson MP. 1994. Secreted forms of β-amyloid precursor protein hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 128:1-12.
19. Greene LA, Tischler AS. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428.
20. Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem. 59:1609-1623.
21. Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM. 1995. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol 131:193-202.
22. Hedley DW, McCulloch EA. 1996. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2. Leukemia 10:1143-1149.
23. Inestrosa NC, Alvarez A, Pérez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J. 1996. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16:881-891.
24. Inestrosa NC, Marzolo MP, Bonnefont AB. 1998. Cellular and molecular basis of estrogen's neuroprotection: potential relevance to Alzheimer's disease. Mol Neurobiol 17:73-86.
25. Inestrosa NC, Reiness CG, Reichardt LF, Hall ZW. 1981. Cellular localization of the molecular forms of acetylcholinesterase in rat pheochromocytoma PC12 cells treated with nerve growth factor. J Neurosci 1:1260-1267.
26. Inestrosa NC, Roberts WL, Marshall TL, Rosenberry TL. 1987. Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterase in other tissues. J Biol Chem 262:4441-4444.
27. Jackson GR, Apffel L, Werrbach-Perez K, Perez-Polo JR. 1990. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J Neurosci Res 25:360-368.
28. Jain A, Martensson J, Stole E, Auld PAM, Meister A. 1991. Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA 88:1913-1917.
29. Klebe RJ, Ruddle FH. 1969. Neuroblastoma: cell culture analyses of a differentiated stem cell system. J Cell Biol 43:69a.
30. Koh JY, Choi DW. 1987. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20:83-90.
31. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. 1997. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17:5089-100.
32. 4. Nature 227:680-685.
33. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. 1993. NMDA-dependent superoxide production and neurotoxicity. Nature 364:535-537.
34. Lander HM, Ogiste JS, Teng KK, Novogrodsky A. 1995. p21 ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem 270:21195-21198.
35. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. 1997. Activation of the receptor for advanced glycation end products triggers a p21 (ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810-17814.
36. Li X, Song L, Jope RS. 1998. Glutathione depletion exacerbates impairment by oxidative stress of phosphoinositide hydrolysis, AP-1, and NF-kappa B activation by cholinergic stimulation. Brain Res Mol Brain Res 53:196-205.
37. Liu Y, Peterson DA, Kimura H, Schubert D. 1997. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69:581-593.
38. Liu Y, Schubert D. 1997. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem 69:2285-2293.
39. 2+ homeostasis and cell death. J Neurosci 15:6239-6249.
40. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. 1997. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 68:255-264.
41. Markesbery WR. 1997. Oxidative stress in Alzheimer's disease. Free Rad Biol Med 23:134-147.
42. Mattson MP. 1997a. Central role of oxyradicals in the mechanism of amyloid β-peptide cytotoxicity. Alzheimers Dis Rev 2:1-14.
43. Mattson MP. 1997b. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081-1132.
44. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65:1740-1751.
45. Mattson MP, Robinson N, Guo Q. 1997. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport 8:3817-3821.
46. Meister A. 1988. Glutathione metabolism and its selective modification. J Biol Chem 263:17205-17208.
47. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65:55-63.
48. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. 1989. Glutamate toxicity in a neural cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558.
49. Olanow CW. 1993. A Radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444.
50. Pan Z, Perez-Polo R. 1993. Role of nerve growth factor in oxidant homeostasis: glutathione metabolism. J Neurochem 61:1713-1721.
51. Pan Z, Perez-Polo R. 1996. Increased uptake of L-cysteine and L-cystine by nerve growth factor in rat pheochromocytoma cells. Brain Res 740:21-26.
52. Pereira CM, Oliveira CR. 1997. Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress. Free Rad Biol Med 23:637-647.
53. Perez-Polo R. 1991. Mechanism of cell death. In: Timiras PS, Giacobini E, Vernadakis A, editors. Plasticity and regeneration of the nervous system. New York: Plenum. p 345-352.
54. Perez-Polo R, Foreman PJ, Jackson GE, Shan D-E, Taglialatela G, Thorpe LW, Werrbach-Perez K. 1990. Nerve growth factor and neuronal cell death. Mol Neurobiol 4:57-91.
55. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. 1995. Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J Neurochem 64:253-265.
56. Prasad KN. 1975. Differentiation of neuroblastoma cells in culture. Biol Rev 50:129-265.
57. Reed DJ, Fariss MW. 1984. Glutathione depletion and susceptibility. Pharmacol Rev 36 Suppl. 25S-33S.
58. Sagara Y, Dargusch R, Chambers D, Davis J, Schubert D, Maher P. 1998. Cellular mechanisms of resistance to chronic oxidative stress. Free Rad Biol Med 24:1375-1389.
59. Sagara Y, Dargush R, Klier FG, Schubert D, Behl C. 1996. Increased antioxidant enzyme activity in amyloid βprotein-resistant cells. J Neurosci 16:497-505.
60. Schubert D, Behl C, Lesley R, Brack A, Dargush R, Sagara Y, Kimura H. 1995. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 92:1989-1993.
61. Shearman MS, Ragan CI, Iversen LL. 1994. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci USA 91:1470-1474.
62. Smith MA, Sayre L, Perry G. 1996. Is Alzheimer's a disease of oxidative stress? Alzheimers Dis Rev 1:63-67.
63. Soto C, Brañes MC, Alvarez J, Inestrosa NC. 1994. Structural determinants of the Alzheimer's amyloid β-peptide. J Neurochem 63:1191-1198.
64. Spitz DR, Sullivan SJ, Malcolm RR, Roberts RJ. 1991. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Rad Biol Med 11:415-423.
65. Tietze F. 1969. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal Biochem 27:502-522.
66. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. 1994. Advanced glycation end products contribute to amyloidogenesis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766-4770.
67. Yankner BA, Duffy LK, Kirshner DA. 1990. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250:279-282.
68. Zhang Y, Tatsuno T, Carney J, Mattson MP. 1993. Basic FGF, NGF, and IGFs protect hippocampal neurons against iron-induced degeneration. J Cereb Blood Flow Metab 13:378-388.